Maternal, fetal, neonatal and breastmilk flecainide concentration during maternal therapy and lactation: a case report
Abstract Background Mothers requiring the antiarrhythmic agent flecainide are often advised not to breastfeed, because of the lack of data concercing neonatal effects and flecainide plasma concentrations following maternal exposure as well as via lactation. This is the first report on combined mater...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | International Breastfeeding Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13006-023-00559-z |